Inoviq Ltd

AU:IIQ Australia Diagnostics & Research
Market Cap
$29.20 Million
AU$47.16 Million AUD
Market Cap Rank
#24790 Global
#520 in Australia
Share Price
AU$0.34
Change (1 day)
+0.00%
52-Week Range
AU$0.32 - AU$0.57
All Time High
AU$4.10
Categories
Companies in Australia Diagnostics & Research
About

INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. It offers non… Read more

Inoviq Ltd (IIQ) - Net Assets

Latest net assets as of December 2025: AU$22.26 Million AUD

Based on the latest financial reports, Inoviq Ltd (IIQ) has net assets worth AU$22.26 Million AUD as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$24.52 Million) and total liabilities (AU$2.26 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$22.26 Million
% of Total Assets 90.79%
Annual Growth Rate 8.73%
5-Year Change -42.48%
10-Year Change 489.8%
Growth Volatility 190.12

Inoviq Ltd - Net Assets Trend (1989–2025)

This chart illustrates how Inoviq Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Inoviq Ltd (1989–2025)

The table below shows the annual net assets of Inoviq Ltd from 1989 to 2025.

Year Net Assets Change
2025-06-30 AU$16.71 Million -16.37%
2024-06-30 AU$19.99 Million +1.89%
2023-06-30 AU$19.62 Million -30.67%
2022-06-30 AU$28.29 Million -2.63%
2021-06-30 AU$29.06 Million +348.74%
2020-06-30 AU$6.48 Million -9.24%
2019-06-30 AU$7.13 Million +531.12%
2018-06-30 AU$1.13 Million +338.28%
2017-06-30 AU$257.94K -90.90%
2016-06-30 AU$2.83 Million +61.23%
2015-06-30 AU$1.76 Million +97.91%
2014-06-30 AU$888.13K -69.55%
2013-06-30 AU$2.92 Million -80.69%
2012-06-30 AU$15.11 Million -43.22%
2011-06-30 AU$26.60 Million +40.83%
2010-06-30 AU$18.89 Million -0.72%
2009-06-30 AU$19.03 Million +235.75%
2008-06-30 AU$5.67 Million +177.26%
2007-06-30 AU$2.04 Million -81.49%
2006-06-30 AU$11.04 Million -34.59%
2005-06-30 AU$16.88 Million +506.93%
2004-06-30 AU$2.78 Million +12.01%
2003-06-30 AU$2.48 Million +6.66%
2002-06-30 AU$2.33 Million -74.39%
1999-06-30 AU$9.09 Million -16.06%
1998-06-30 AU$10.83 Million +3.73%
1997-06-30 AU$10.44 Million +1.32%
1996-06-30 AU$10.31 Million +4.18%
1995-06-30 AU$9.89 Million +1.75%
1994-06-30 AU$9.72 Million +503.66%
1993-06-30 AU$1.61 Million +463.29%
1992-06-30 AU$286.00K +1343.48%
1991-06-30 AU$-23.00K -109.16%
1990-06-30 AU$251.00K -69.43%
1989-06-30 AU$821.00K --

Equity Component Analysis

This analysis shows how different components contribute to Inoviq Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 5515796800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$78.05 Million 466.96%
Other Comprehensive Income AU$1.66 Million 9.96%
Other Components AU$1.00 0.00%
Total Equity AU$16.71 Million 100.00%

Inoviq Ltd Competitors by Market Cap

The table below lists competitors of Inoviq Ltd ranked by their market capitalization.

Company Market Cap
SEONGAN CO. Ltd
KO:011300
 		$23.33 Million
The Intergroup Corporation
NASDAQ:INTG
 		$23.34 Million
Camus Engineering & Construction Inc
KO:013700
 		$23.34 Million
EVERFUEL A/S DK -10
F:0HR
 		$23.34 Million
MFC Asset Management Public Company Limited
BK:MFC
 		$23.33 Million
VBARE Iberian Properties SOCIMI SA
MC:YVBA
 		$23.33 Million
Reckon Ltd
AU:RKN
 		$23.33 Million
Electro Aço Altona S.A
SA:EALT3
 		$23.32 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Inoviq Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 19,986,328 to 16,714,434, a change of -3,271,894 (-16.4%).
  • Net loss of 6,932,280 reduced equity.
  • Share repurchases of 2,629,000 reduced equity.
  • Other comprehensive income decreased equity by 112,058.
  • Other factors increased equity by 6,401,444.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$-6.93 Million -41.47%
Share Repurchases AU$2.63 Million -15.73%
Other Comprehensive Income AU$-112.06K -0.67%
Other Changes AU$6.40 Million +38.3%
Total Change AU$- -16.37%

Book Value vs Market Value Analysis

This analysis compares Inoviq Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.23x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.04x to 2.23x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1989-06-30 AU$8.74 AU$0.34 x
1990-06-30 AU$2.67 AU$0.34 x
1991-06-30 AU$-0.24 AU$0.34 x
1992-06-30 AU$3.05 AU$0.34 x
1993-06-30 AU$16.20 AU$0.34 x
1994-06-30 AU$87.41 AU$0.34 x
1995-06-30 AU$48.85 AU$0.34 x
1996-06-30 AU$48.50 AU$0.34 x
1997-06-30 AU$49.13 AU$0.34 x
1998-06-30 AU$45.36 AU$0.34 x
1999-06-30 AU$37.58 AU$0.34 x
2002-06-30 AU$6.29 AU$0.34 x
2003-06-30 AU$5.04 AU$0.34 x
2004-06-30 AU$6.72 AU$0.34 x
2005-06-30 AU$18.83 AU$0.34 x
2006-06-30 AU$8.35 AU$0.34 x
2007-06-30 AU$1.30 AU$0.34 x
2008-06-30 AU$3.54 AU$0.34 x
2009-06-30 AU$8.45 AU$0.34 x
2010-06-30 AU$6.81 AU$0.34 x
2011-06-30 AU$7.94 AU$0.34 x
2012-06-30 AU$4.01 AU$0.34 x
2013-06-30 AU$0.77 AU$0.34 x
2014-06-30 AU$0.24 AU$0.34 x
2015-06-30 AU$0.40 AU$0.34 x
2016-06-30 AU$0.34 AU$0.34 x
2017-06-30 AU$0.01 AU$0.34 x
2018-06-30 AU$0.05 AU$0.34 x
2019-06-30 AU$0.21 AU$0.34 x
2020-06-30 AU$0.14 AU$0.34 x
2021-06-30 AU$0.38 AU$0.34 x
2022-06-30 AU$0.31 AU$0.34 x
2023-06-30 AU$0.21 AU$0.34 x
2024-06-30 AU$0.22 AU$0.34 x
2025-06-30 AU$0.15 AU$0.34 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Inoviq Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -41.47%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -381.88%
  • • Asset Turnover: 0.10x
  • • Equity Multiplier: 1.10x
  • Recent ROE (-41.47%) is above the historical average (-110.84%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1989 -596.83% 0.00% 0.00x 1.22x AU$-4.98 Million
1990 -209.96% 0.00% 0.00x 2.48x AU$-552.10K
1991 0.00% 0.00% 0.00x 0.00x AU$-441.70K
1992 -208.04% 0.00% 0.00x 1.29x AU$-623.60K
1993 1.55% 0.00% 0.00x 1.45x AU$-136.10K
1994 -4.58% 0.00% 0.00x 1.08x AU$-1.42 Million
1995 1.71% 0.00% 0.00x 1.06x AU$-820.50K
1996 0.13% 0.00% 0.00x 1.11x AU$-1.02 Million
1997 1.30% 0.00% 0.00x 1.08x AU$-908.64K
1998 -6.09% 0.00% 0.00x 1.07x AU$-1.74 Million
1999 -17.45% 0.00% 0.00x 1.04x AU$-2.50 Million
2002 -0.22% -0.40% 0.43x 1.24x AU$-236.08K
2003 0.44% 1.77% 0.23x 1.08x AU$-236.72K
2004 -0.01% -0.10% 0.10x 1.26x AU$-277.37K
2005 0.01% 0.46% 0.02x 1.03x AU$-1.69 Million
2006 -92.51% -13150.37% 0.01x 1.14x AU$-11.32 Million
2007 -542.39% 0.00% 0.00x 1.36x AU$-11.29 Million
2008 55.78% 55.28% 0.93x 1.08x AU$2.59 Million
2009 19.78% 31947.04% 0.00x 1.05x AU$1.86 Million
2010 -8.50% -878.12% 0.01x 1.04x AU$-3.49 Million
2011 -5.86% -30219.03% 0.00x 1.01x AU$-4.22 Million
2012 -69.17% -3789.93% 0.02x 1.08x AU$-11.96 Million
2013 -360.47% 0.00% 0.00x 1.45x AU$-10.81 Million
2014 -85.46% 0.00% 0.00x 3.18x AU$-847.81K
2015 -169.77% 0.00% 0.00x 1.05x AU$-3.16 Million
2016 -115.42% 0.00% 0.00x 1.16x AU$-3.55 Million
2017 -1009.62% -5914.81% 0.06x 2.82x AU$-2.63 Million
2018 -160.73% -2911.02% 0.04x 1.29x AU$-1.93 Million
2019 -24.07% -19670.94% 0.00x 1.07x AU$-2.43 Million
2020 -50.25% -3306.79% 0.01x 1.14x AU$-3.90 Million
2021 -38.38% -877.34% 0.04x 1.15x AU$-14.06 Million
2022 -64.31% -6575.01% 0.01x 1.09x AU$-21.03 Million
2023 -45.72% -2252.43% 0.02x 1.10x AU$-10.93 Million
2024 -32.79% -1224.78% 0.02x 1.09x AU$-8.55 Million
2025 -41.47% -381.88% 0.10x 1.10x AU$-8.60 Million

Industry Comparison

This section compares Inoviq Ltd's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

  • Industry: Diagnostics & Research
  • Average net assets among peers: $176,935,516
  • Average return on equity (ROE) among peers: -18.57%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Inoviq Ltd (IIQ) AU$22.26 Million -596.83% 0.10x $23.33 Million
Australian Clinical Labs Ltd (ACL) $68.99 Million 59.80% 4.31x $217.50 Million
Bcal Diagnostics Ltd (BDX) $6.22 Million -116.40% 0.59x $10.33 Million
Capitol Health Ltd (CAJ) $144.04 Million 0.60% 0.82x $222.66 Million
Cryosite Ltd (CTE) $1.45 Million 126.98% 12.60x $5.03 Million
Genetic Signatures Ltd (GSS) $16.18 Million -10.68% 0.02x $8.20 Million
Healius Ltd (HLS) $1.04 Billion -62.05% 1.87x $208.81 Million
Microba Life Sciences Ltd (MAP) $32.49 Million -45.98% 0.46x $10.42 Million
Monash Ivf Group Ltd (MVF) $268.44 Million 9.37% 0.33x $116.82 Million
Pacific Edge Ltd (PEB) $13.91 Million -128.81% 0.19x $89.67 Million